ロード中...
CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells
CUDC-907 is a novel dual-acting inhibitor of phosphoinositide 3-kinase (PI3K) and histone deacetylase (HDAC). In this study, we aimed to explore the anticancer effects of CUDC-907 on human breast cancer cells. Our results showed that CUDC-907 effectively inhibited breast cancer cell proliferation. F...
保存先:
| 出版年: | J Cell Commun Signal |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Netherlands
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7642015/ https://ncbi.nlm.nih.gov/pubmed/32200503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-020-00558-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|